Macrogenics (MGNX) Capital Expenditures (2012 - 2026)
Macrogenics (MGNX) reported Capital Expenditures of $276000.0 for Q1 2026, down 47.83% year-over-year from $529000.0 in Q1 2025, and up 13.11% quarter-over-quarter from $244000.0 in Q4 2025.
Macrogenics (MGNX) Capital Expenditures (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Capital Expenditures data on file, last reported at $276000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $276000.0, down 47.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (down 40.17% YoY), and the FY2025 annual result was $1.9 million, down 48.35% from the prior year.
- Capital Expenditures improved to $276000.0 in Q1 2026 per MGNX's latest filing, from $244000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.3 million in Q4 2022 and troughed at -$2.1 million in Q3 2022.
- A 5-year average of $705187.5 and a median of $620000.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures tumbled 145.26% in 2022, then soared 724.29% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $3.3 million in 2022, then sank by 81.37% to $620000.0 in 2023, then changed by 0.0% to $620000.0 in 2024, then plunged by 60.65% to $244000.0 in 2025, then rose by 13.11% to $276000.0 in 2026.
- Business Quant data shows MGNX's Capital Expenditures at $276000.0 in Q1 2026, $244000.0 in Q4 2025, and $426000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 276,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 276,000.00 |
| Mar 31, 2026 | 276,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2025 | 244,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Jun 30, 2025 | 715,000.00 |
| Jun 30, 2025 | 715,000.00 |
| Mar 31, 2025 | 529,000.00 |
| Mar 31, 2025 | 529,000.00 |
| Dec 31, 2024 | 620,000.00 |
| Dec 31, 2024 | 620,000.00 |
| Sep 30, 2024 | 592,000.00 |
| Sep 30, 2024 | 592,000.00 |
| Jun 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 620,000.00 |
| Dec 31, 2023 | 620,000.00 |